Mittie Doyle, Chief Medical Officer: Avalo Therapeutics AVTX Sell · Filed 03/18

Trade details

Type: Insider sale
Amount: $411,695.8
Shares · price: 25,492 sh · $16.15 a share
Held after: 3,622 sh
Stock: Avalo Therapeutics AVTX
Person: Mittie DoyleChief Medical Officer
Trade date: 26/03/16
Filed: 26/03/18
Days to filing: 2 days

Sold 87.6% of holdings

Share of holding sold: 87.6%

Avalo Therapeutics trades, last 26 weeks

What else happened in Avalo Therapeutics around then

Filed or reported within 30 days of the trade day · 02/14~04/15

Mittie Doyle's recent trades

Mittie DoyleChief Medical Officer
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$98.7K
5,037 sh
$98.7K
Filed 08/17
Traded 08/17
Mittie DoyleChief Medical Officer
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$12.4K
679 sh
$12.4K
Filed 08/10
Traded 08/10
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$26.1K
1,450 sh
$26.1K
Filed 06/25
Traded 06/23
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$10.9K
679 sh
$10.9K
Filed 06/01
Traded 05/28
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$56.3K
3,000 sh
$56.3K
Filed 05/19
Traded 05/15